“Our free press” squeals with joy over Merck’s iffy and unnecessary Molnupiravir, based on one tiny, preliminary study

… whereas they’ve avidly pooh-poohed HCQ and Ivermectin as early treatments for COVID-19, although the safety and effectiveness of both those drugs is amply documented.

All of them hookers.


The Extraordinary Hypocrisy of Molnupiravir

The Representation of Merck’s Molnupiravir as a “Game Changer” Only Underscores a Bias – And Merck Has Other Data It Is Not Sharing

Trigger alert: This article may upset those who care about other human beings.

Molnupiravir (mull-noo-’peer-aveer) is the talk of the town, belle of the ball in the press. “Game changer” is the word on the street, according to a message to Science Insider:

“Molnupiravir is unquestionably a game changer! The large effect size, and the ease of administration change the paradigm of mild COVID-19 treatment with a potential to reduce COVID-19 death rates.” See: Science Magazine

The hype even included Fauci going on in an interview about how the idea that molnupiravir is so effective that the vaccine won’ t be needed.

Click on the link for the rest.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.